Evidence map›Paper›PMID 37396836›Full record

ReviewRSC advances2023

Fighting bacterial pathogens with carbon nanotubes: focused review of recent progress.

Mihaela Asaftei, Massimiliano Lucidi, Cristina Cirtoaje, Alina-Maria Holban, Costas A Charitidis, Fang Yang, Aiguo Wu, George A Stanciu, Özge Sağlam, Veronica Lazar and 2 more

Abstract readReview
In one paragraph

Review in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mihaela AsafteiCenter for Microscopy-Microanalysis and Information Processing, University Politehnica of Bucharest Romania stefan.g.stanciu@upb.ro.ORCID https://orcid.org/0000-0002-2532-4285
Massimiliano LucidiDepartment of Science, Roma Tre University Rome 00146 Italy paolo.visca@uniroma3.it.ORCID https://orcid.org/0000-0003-3238-9164
Cristina CirtoajeDepartment of Physics, University Politehnica of Bucharest Romania.ORCID https://orcid.org/0000-0002-7193-5554
Alina-Maria HolbanDepartment of Microbiology, University of Bucharest Romania.ORCID https://orcid.org/0000-0002-1257-5042
Costas A CharitidisResearch Lab of Advanced, Composite, Nano-Materials and Nanotechnology, School of Chemical Engineering, National Technical University of Athens Greece.ORCID https://orcid.org/0000-0003-1367-7603
Fang YangCIXI Institute for Biomedical Engineering, Ningbo Institute for Materials Technology and Engineering, Chinese Academy of Sciences China.ORCID https://orcid.org/0000-0001-6966-9464
Aiguo WuCIXI Institute for Biomedical Engineering, Ningbo Institute for Materials Technology and Engineering, Chinese Academy of Sciences China.ORCID https://orcid.org/0000-0001-7200-8923
George A StanciuCenter for Microscopy-Microanalysis and Information Processing, University Politehnica of Bucharest Romania stefan.g.stanciu@upb.ro.ORCID https://orcid.org/0000-0002-7597-1819
Özge SağlamDepartment of Mechanical Engineering, İzmir University of Economics Turkey.ORCID https://orcid.org/0000-0002-5583-3662
Veronica LazarDepartment of Microbiology, University of Bucharest Romania.
Paolo ViscaDepartment of Science, Roma Tre University Rome 00146 Italy paolo.visca@uniroma3.it.ORCID https://orcid.org/0000-0002-6128-7039
Stefan G StanciuCenter for Microscopy-Microanalysis and Information Processing, University Politehnica of Bucharest Romania stefan.g.stanciu@upb.ro.ORCID https://orcid.org/0000-0002-1676-3040

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The fast and global spread of bacterial resistance to currently available antibiotics results in a great and urgent need for alternative antibacterial agents and therapeutic strategies. Recent studies on the application of nanomaterials as antimicrobial agents have demonstrated their potential for the management of infectious diseases. Among the diverse palette of nanomaterials currently used in biomedical applications, carbon nanotubes (CNTs) have gained massive interest given their many valuable properties, such as high thermal and electrical conductivity, tensile strength, flexibility convenient aspect ratio, and low fabrication costs. All these features are augmented by facile conjugation with functional groups. CNTs are currently available in many configurations, with two main categories being single-walled and multi-walled CNTs, depending on the number of rolled-up single-layer carbon atoms sheets making up the nanostructure. Both classes have been identified over the past years as promising antibacterial agents but the current level of understanding of their efficiency still harbors many pending questions. This mini-review surveys recent progress on the topic of antibacterial effects of CNTs and examines the proposed mechanisms of action(s) of different CNT typologies, placing the main focus on past studies addressing the antibacterial activity on

Identifiers

PMID37396836
PMCPMC10308885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.